Delivery Order SPE2DR25D2206-SPE2DR26F9FV3
- Not listed
- The Defense Logistics Agency awarded a $3,214.86 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes in 0.5 ml quantities, with final delivery due by August 12, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $28,778.14 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 ml syringes on September 26, 2025, with completion scheduled for September 29, 2025. This competitively awarded, firm fixed-price delivery order supports pharmaceutical supply needs for military and federal healthcare systems, with performance based at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes valued at $8,591.59, with an ultimate completion date of October 15, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The award was competitively procured...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $47,007.95. This is a firm fixed-price delivery order with no set-aside designation, placing performance at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,454.71 on September 10, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed price, competitively awarded contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.23 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of June 23, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL unit doses. This firm fixed-price delivery order, valued at $7,614.34, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. The contract utilizes no set-aside designation and represents a competitive award under the contractor's existing indefinite delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is valued at $5,659.98 and is for the delivery of the pharmaceutical product phytonadione 1 mg/0.5 mL syringe, 0.5 mL. This delivery order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 0.5 mL syringes of phytonadione 1 mg. The contract has a potential value of $2,046.70 and a completion date of February 2, 2024. This award is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025, which serves as the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 10 mg/ml in ampule form, with a contract ceiling value of $2,026.26 and an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order carries firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FV3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,833.10 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes. This is a firm fixed price delivery order with an ultimate completion date of December 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive portfolio of medications and medical supplies to support military healthcare systems and other government agencies. The parent IDC serves as a global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other medical commodities across multiple therapeutic domains to defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 12/14/25 |